A 3,5-Di-tert-4-butylhydroxytoluene (BHT) DMF (Drug Master File) is a document detailing the whole manufacturing process of 3,5-Di-tert-4-butylhydroxytoluene (BHT) active pharmaceutical ingredient (API) in detail. Different forms of 3,5-Di-tert-4-butylhydroxytoluene (BHT) DMFs exist exist since differing nations have different regulations, such as 3,5-Di-tert-4-butylhydroxytoluene (BHT) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3,5-Di-tert-4-butylhydroxytoluene (BHT) DMF submitted to regulatory agencies in the US is known as a USDMF. 3,5-Di-tert-4-butylhydroxytoluene (BHT) USDMF includes data on 3,5-Di-tert-4-butylhydroxytoluene (BHT)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3,5-Di-tert-4-butylhydroxytoluene (BHT) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3,5-Di-tert-4-butylhydroxytoluene (BHT) suppliers with USDMF on PharmaCompass.